Search - tctmd.com

Displaying 21 - 40 of 392

Sort: Relevancy | Date

News Conference News HRS 2025

Pairing CIED Lead Extraction With Tricuspid Interventions Appears Safe

Todd Neale

April 28, 2025

News Daily News

LuX-Valve TTVR Device Provides Favorable 1-Year Results

Yael L. Maxwell

April 24, 2025

News Daily News

CMS Releases Proposed Decision Memo for Tricuspid TEER

L.A. McKeown

April 04, 2025

News Conference News ACC 2025

By 2 Years, Tricuspid TEER Reduces Hospitalizations for HF: TRILUMINATE

Michael O'Riordan

March 31, 2025

Presentation ACC 2025

Two-year Outcomes Of Transcatheter Tricuspid Valve Edge-to-Edge Repair For Tricuspid Regurgitation: The TRILUMINATE Pivotal Trial

Presenter: Saibal Kar

March 30, 2025

News Opinion Editor's Corner ACC 2025

What’s Going to Be Hot at ACC 2025?

Michael O'Riordan

March 26, 2025

News Daily News

CMS Agrees to Reimburse Transcatheter Tricuspid Valve Replacement

Todd Neale

March 20, 2025

News Conference News THT 2025

Questioning the KCCQ: Experts Debate Its Validity as QoL Metric

Todd Neale

February 19, 2025

News Daily News

Intermediate Disease May Be the ‘Sweet Spot’ for T-TEER Survival Benefit

Yael L. Maxwell

February 12, 2025

News Conference News STS 2025

Surgeons: Be Active in Tricuspid Procedures or Be ‘Left Behind’

Yael L. Maxwell

February 05, 2025

News Daily News

Top Structural Heart News of 2024

L.A. McKeown

December 29, 2024

News Opinion CV Team Dispatch

December 2024 Dispatch for the CV Team

L.A. McKeown

December 20, 2024

News Conference News PCR London Valves 2024

Reverse Remodeling and Higher Stroke Volume With TEER: TRILUMINATE

Michael O'Riordan

December 03, 2024

News Conference News PCR London Valves 2024

Residual TR After Treating Mitral ViV Disease Linked to Worse Outcomes

Michael O'Riordan

November 26, 2024

News Conference News PCR London Valves 2024

Live Valve Cases Safe, With Outcomes Comparable to Trials and Practice

Michael O'Riordan

November 25, 2024

News Conference News TCT 2024

Percutaneous Mechanical Aspiration Promising for Right-Heart Infective Endocarditis

Caitlin E. Cox

November 08, 2024

News Conference News TCT 2024

TRISCEND II: Full Results a Win for TTVR in Severe Tricuspid Regurgitation

Michael O'Riordan

October 30, 2024

Presentation TCT 2024

TRISCEND II Trial: Transcatheter Valve Replacement vs. Optimal Medical Therapy for Severe Tricuspid Regurgitation

Presenter: Susheel Kodali

October 30, 2024

Presentation TCT 2024

TCT 980: The Impact of Residual Tricuspid Regurgitation on Long-term Clinical Outcomes, Following Tricuspid Transcatheter Edge-to-Edge Repair

Presenter: Patrascu Ionut Alexandru

October 29, 2024

Presentation TCT 2024

TCT 978: A Computational Modeling Strategy to Study Transcatheter Tricuspid Valve Replacements in Patients With Severe Tricuspid Regurgitation

Presenter: Luis Rene Mata Quinonez

October 29, 2024

Advertisement

Pairing CIED Lead Extraction With Tricuspid Interventions Appears Safe

LuX-Valve TTVR Device Provides Favorable 1-Year Results

CMS Releases Proposed Decision Memo for Tricuspid TEER

By 2 Years, Tricuspid TEER Reduces Hospitalizations for HF: TRILUMINATE

Two-year Outcomes Of Transcatheter Tricuspid Valve Edge-to-Edge Repair For Tricuspid Regurgitation: The TRILUMINATE Pivotal Trial

What’s Going to Be Hot at ACC 2025?

CMS Agrees to Reimburse Transcatheter Tricuspid Valve Replacement

Questioning the KCCQ: Experts Debate Its Validity as QoL Metric

Intermediate Disease May Be the ‘Sweet Spot’ for T-TEER Survival Benefit

Surgeons: Be Active in Tricuspid Procedures or Be ‘Left Behind’

Top Structural Heart News of 2024

December 2024 Dispatch for the CV Team

Reverse Remodeling and Higher Stroke Volume With TEER: TRILUMINATE

Residual TR After Treating Mitral ViV Disease Linked to Worse Outcomes

Live Valve Cases Safe, With Outcomes Comparable to Trials and Practice

Percutaneous Mechanical Aspiration Promising for Right-Heart Infective Endocarditis

TRISCEND II: Full Results a Win for TTVR in Severe Tricuspid Regurgitation

TRISCEND II Trial: Transcatheter Valve Replacement vs. Optimal Medical Therapy for Severe Tricuspid Regurgitation

TCT 980: The Impact of Residual Tricuspid Regurgitation on Long-term Clinical Outcomes, Following Tricuspid Transcatheter Edge-to-Edge Repair

TCT 978: A Computational Modeling Strategy to Study Transcatheter Tricuspid Valve Replacements in Patients With Severe Tricuspid Regurgitation

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content